Pier Capital’s Dynavax Technologies DVAX Stock Holding History

Pier Capital’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-2,181	Closed	-$53K	–	115
2015 Q4	$53K	Sell	2,181 -247,062	-99%	-$6.19M	0.01%	111
2015 Q3	$6.12M	Buy	+249,243	New	+$7.06M	1%	57

Other funds holding DVAX

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Amici Capital New York $257M AUM 4.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Glenhill Advisors New York $6.94M AUM 24.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Pier Capital's DVAX Position: Q1 2016 in Review

Pier Capital sold out of Dynavax Technologies (DVAX) in Q1 2016, closing a stake of 2,181 shares — an estimated $53K sold.

Pier Capital first reported a position in DVAX in Q3 2015 and held it in 2 quarters. The position peaked at $6.12M in Q3 2015. 130 funds tracked by Wall St. Rank hold DVAX as of Q1 2016.

Pier Capital reported no remaining Dynavax Technologies position as of Q1 2016 after selling out during the quarter.
Pier Capital sold 2,181 Dynavax Technologies shares in Q1 2016, an estimated $53K.
Pier Capital first reported a position in Dynavax Technologies in Q3 2015 and held it in 2 quarters.
Pier Capital's Dynavax Technologies position peaked at $6.12M in Q3 2015.
130 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2016.

Based on Pier Capital's 13F filing for Q1 2016, filed 5 May 2016.